journal article·2014-08

Contrasting effects of cysteine modification on the transfection efficiency of amphipathic peptides

Rajpal Sharma, Daniel Nisakar, Shivangi Shivpuri, Munia Ganguli

Biomaterials· Volume 35· Issue 24
Publisher page

Abstract

Delivery of DNA to cells remains a key challenge towards development of gene therapy. A better understanding of the properties involved in stability and transfection efficiency of the vector could critically contribute to the improvement of delivery vehicles. In the present work we have chosen two peptides differing only in amphipathicity and explored how presence of cysteine affects DNA uptake and transfection efficiency. We report an unusual observation that addition of cysteine selectively increases transfection efficiency of secondary amphipathic peptide (Mgpe-9) and causes a drop in the primary amphipathic peptide (Mgpe-10). Our results point the effect of cysteine is dictated by the importance of physicochemical properties of the carrier peptide. We also report a DNA delivery agent Mgpe-9 exhibiting high transfection efficiency in multiple cell lines (including hard-to-transfect cell lines) with minimal cytotoxicity which can be further explored for in vivo applications.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Nonviral gene delivery: principle, limitations, and recent progress
2. Progress and problems with the use of viral vectors for gene therapy10.1038/nrg1066 ↗
3. A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios10.1038/ncomms4053 ↗
4. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids10.1038/ncomms2886 ↗
5. Overcoming nonviral gene delivery barriers: perspective and future10.1021/mp400467x ↗
6. Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies10.1016/j.ijpharm.2011.07.013 ↗
7. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection10.1038/sj.gt.3300865 ↗
8. Effects of erythrocytes and serum proteins on lung accumulation of lipoplexes containing cholesterol or DOPE as a helper lipid in the single-pass rat lung perfusion system10.1016/S0939-6411(01)00165-5 ↗
9. Barriers to non-viral vector-mediated gene delivery in the nervous system10.1007/s11095-010-0364-7 ↗
10. Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons10.1016/S0165-0270(03)00125-0 ↗
11. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics10.1111/j.1476-5381.2009.00057.x ↗
12. Peptides in DNA delivery: current insights and future directions10.1016/j.drudis.2007.11.008 ↗
13. Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems10.1038/ncomms1952 ↗
14. Arginine clustering on calix[4]arene macrocycles for improved cell penetration and DNA delivery10.1038/ncomms2721 ↗
15. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine10.1021/bc0100455 ↗
16. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q ↗
17. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy10.1182/blood.V97.8.2221 ↗
18. Gene delivery with synthetic (non viral) carriers10.1016/S0378-5173(01)00861-4 ↗
19. Atomic force microscopic analysis of the influence of the molecular weight of poly(L)lysine on the size of polyelectrolyte complexes formed with DNA
20. Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes10.1089/hum.1994.5.9-1095 ↗
21. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery10.1089/hum.1996.7.12-1437 ↗
22. A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells
23. Peptide-mediated gene delivery: influence of peptide structure on gene expression10.1021/bc960079q ↗
24. Branched cationic peptides for gene delivery: role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes10.1089/10430349950019101 ↗
25. Metabolic stability of glutaraldehyde cross-linked peptide DNA condensates10.1021/js990042p ↗
26. Triggered intracellular activation of disulfide crosslinked polyelectrolyte gene delivery complexes with extended systemic circulation in vivo10.1038/sj.gt.3301446 ↗
27. Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers10.1021/bc000056i ↗
28. Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates10.1002/(SICI)1520-6017(200004)89:4<499::AID-JPS7>3.0.CO;2-V ↗
29. Cross-linked low molecular weight glycopeptide-mediated gene delivery: relationship between DNA metabolic stability and the level of transient gene expression in vivo10.1002/jps.1152 ↗
30. Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors10.1021/ja016440n ↗
31. Caged DNA does not aggregate in high ionic strength solutions10.1021/bc9801530 ↗
32. Self-assembly of DNA-polymer complexes using template polymerization10.1093/nar/26.18.4178 ↗
33. Delivery of nucleic acids via disulfide-based carrier systems10.1002/adma.200802453 ↗
34. A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids10.1093/nar/gni085 ↗
35. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes10.1016/j.jconrel.2004.09.018 ↗
36. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities10.1016/S0169-409X(02)00179-5 ↗
37. An endosomolytic tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection10.1016/j.biomaterials.2008.01.031 ↗
38. Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery10.1038/mt.2010.242 ↗
39. (LYS)(16)-based reducible polycations provide stable polyplexes with anionic fusogenic peptides and efficient gene delivery to post mitotic cells10.1016/j.bbagen.2007.06.009 ↗
40. A potent new class of reductively activated peptide gene delivery agents10.1074/jbc.275.14.9970 ↗
41. Linear short histidine and cysteine modified arginine peptides constitute a potential class of DNA delivery agents10.1021/mp400353n ↗
42. Vectors based on reducible polycations facilitate intracellular release of nucleic acids10.1002/jgm.331 ↗
43. Molecular parameters of siRNA–cell penetrating peptide nanocomplexes for efficient cellular delivery10.1021/nn305754c ↗
44. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy10.1016/S0006-3495(98)77987-1 ↗
45. Structural rearrangements and chemical modifications in known cell penetrating peptide strongly enhance DNA delivery efficiency10.1016/j.jconrel.2011.09.081 ↗
46. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery10.1021/mp400032q ↗
47. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery10.1021/bc034140k ↗
48. Targeted drug conjugates: principles and progress10.1016/S0169-409X(01)00227-7 ↗
49. A review of stimuli-responsive nanocarriers for drug and gene delivery10.1016/j.jconrel.2007.12.017 ↗
50. Surface decorated gold nanoparticles by linear and cyclic peptides as molecular transporters10.1021/mp400199e ↗
51. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs10.1021/mp3004034 ↗
52. Cell-surface thiols affect cell entry of disulfide-conjugated peptides
53. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(L-lysine): a potential carrier for systemic delivery of antisense DNA10.1021/bm000142l ↗
55. In silico approach for predicting toxicity of peptides and proteins10.1371/journal.pone.0073957 ↗